Carbon monoxide overproduced by heme oxygenase-1 causes a reduction of vascular resistance in perfused rat liver

Yoshiyuki Wakabayashi1, Rina Takamiya1, Akira Mizuki2, Takanori Kyokane1, Nobuhito Goda1, Tokio Yamaguchi3, Shinji Takeoka4, Eishun Tsuchida4, Makoto Suematsu1, and Yuzuru Ishimura1

1 Department of Biochemistry, School of Medicine, Keio University, 2 Department of Medicine, Saisei-kai Central Hospital, 4 Department of Polymer Chemistry, Waseda University, and 3 Department of Biochemical Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 160, Japan


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

This study aimed to examine whether livers overexpressing heme oxygenase (HO)-1 could alter the vascular resistance through the vasorelaxing action of carbon monoxide (CO). The relationship among HO-1 expression, CO generation, and the vascular resistance was assessed in perfused rat livers pretreated with hemin, an inducer of HO-1. At 18 h after the hemin treatment, livers displayed marked increases in HO-1 expression in hepatocytes and venous CO flux and a reduction of the basal resistance. The reduction of the resistance in hemin-treated livers was canceled by administration of oxyhemoglobin, a reagent trapping both CO and nitric oxide (NO), but not by methemoglobin, which captures NO but not CO. Liposome-encapsulated oxyhemoglobin, which cannot access the space of Disse, did not cause vasoconstriction. Furthermore, these livers became less sensitive to endothelin-1, a vasoconstrictive peptide, than the untreated controls through mechanisms involving CO. On the other hand, at 12 or 24 h after the treatment when the HO-1 induction was not accompanied by CO overproduction, neither a decrease in the basal resistance nor vascular hyporeactivity to endothelin-1 was observed. These results suggest that CO overproduced in the extrasinusoidal compartment is a determinant of the HO-1-mediated vasorelaxation in the liver.

heat shock protein 32; cytochrome P-450; hepatic sinusoids; hemoglobin; methemoglobin


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

HEME OXYGENASE (HO) is an enzyme responsible for the degradation of protoheme IX to form biliverdin, free iron, and carbon monoxide (CO). The enzyme exists in three isoforms: HO-1 (28), HO-2 (15), and HO-3 (16). Among them, HO-1, which is identical to heat shock protein 32, is induced by a variety of stimuli such as cytokines, heavy metals, and oxidants (14). This inducible isoform can also be upregulated by protoheme IX (iron protoporphyrin IX) (15), the substrate for HO. Approximately 70% of the heme degraded in the body is derived from hemoglobin from senescent erythrocytes (14).

Liver is one of the major organs in which the heme molecules are oxidatively degraded by HO, and its capacity to decompose the heme is increased by the HO-1 induction. Recent studies also revealed that induction of HO-1 occurred in the liver in response to endotoxemia (6) and hemorrhagic shock (2). The hepatic HO-1 expression could also be markedly elevated when amounts of free heme molecules in circulation are acutely increased. Such circumstances involve massive hemolysis by sepsis (27), excessive blood transfusion, and splenectomy (35).

Recently, several lines of evidence indicated that CO produced by the HO reaction contributes to regulation of cell functions by activating soluble guanylate cyclase (4, 36) or by hyperpolarizing membrane potentials through the mechanisms involving stimulation of potassium channels (21). Although these previous studies suggest a possible role of the endogenous CO-generating system in regulation of cell and organ functions, the relationship between actual CO amounts released through the endogenous origins and resultant influences on the cell function have not yet been fully investigated. We have shown in the liver that CO endogenously generated by the HO reaction is necessary to maintain sinusoidal vessels in a relaxing state (32, 33). Administration of zinc protoporphyrin IX (ZnPP), a potent inhibitor of HO, or of free oxyhemoglobin (HbO2), a trapping agent of CO, markedly increased the vascular resistance concurrent with sinusoidal constriction. HbO2 can diffuse across the fenestrated endothelium of the liver into the space of Disse and thereby entrap CO in the extrasinusoidal space. Considering that hepatocytes that constitutively express HO-2 are the major sites for CO generation, these results suggested that CO generated by HO-2 serves as a regulator of sinusoidal tone under ordinary conditions (10). Such a physiological role of CO constitutively generated by HO-2 raised a question as to whether the liver undergoing stress conditions alters its vascular function through overproduction of CO as a consequence of the HO-1 induction. The present study was thus undertaken to demonstrate time history and topographic distribution of the HO-1 expression, their relationship with quantitative evaluation of local CO generation, and its functional link to vascular tone.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents. Anti-rat HO-1 and HO-2 antibodies were prepared and purified as described elsewhere (10). ZnPP was purchased from Aldrich Chemical (Milwaukee, WI). Other reagents used were purchased from Sigma Chemical (St. Louis, MO) unless otherwise mentioned.

Preparation of hemoglobin and liposome-encapsulated hemoglobin vesicles. To examine the role of endogenously generated CO in the regulation of vascular tone in the liver, free and liposome-encapsulated hemoglobins, hereafter designated as free Hb and HbV, respectively, were used as a tool to trap CO in and around the sinusoidal space. Free Hb, HbV, and methemoglobin (metHb) were prepared using outdated human erythrocytes as described previously (23, 24). metHb was used as a tool to scavenge nitric oxide (NO) but not CO. The mean value of the diameter of HbV used in the present study was ~0.25 µm. Previous studies (22) revealed that, when administered into the systemic circulation, HbV with this size was partly captured in tissue macrophages including Kupffer cells but did not enter the hepatic parenchyma. On the other hand, free Hb was readily trapped by the parenchymal cells because of the presence of fenestration in sinusoidal endothelium, the diameter of which ranges from 0.10 to 0.15 µm (18, 37). The oxygen-binding affinity exhibited no substantial differences between HbV and free Hb, as described previously (23). Both free Hb and HbV were used for experiments within 7 days after the preparation procedures.

Animal preparation and hemin treatment. Male Wistar rats (260-280 g) were obtained from Saitama Animal Laboratory (Saitama, Japan). All animals were allowed free access to laboratory chow and tap water. Rats were pretreated with hemin via an intraperitoneal injection (40 µmol/kg). They were anesthetized intraperitoneally with pentobarbital sodium (50 mg/kg), and the common bile duct was cannulated by a polyethylene (PE)-10 catheter. The livers were excised and perfused with Hb- and albumin-free Krebs-Henseleit bicarbonate-buffered solution (pH 7.4, 37°C) gassed 95% O2-5% CO2 containing 30 µM taurocholate as described previously (25, 40). The perfusate was pumped through the liver with a peristaltic pump at a constant rate of 4.0 ml · min-1 · g liver weight-1 in a single pass mode while the inlet perfusion pressure was monitored (40).

Experimental protocols. Five main protocols were employed to compare the differences in the vascular resistance between the control and the hemin-treated livers. Livers in the first, second, and third groups were treated with HbO2, HbV-O2, and metHb, respectively. Concentrations of the Hb derivatives were all 0.5 g/dl and were usually perfused for 10 min. In the fourth group, 1 µM ZnPP, an HO inhibitor, was applied to the perfusate. In the fifth group, the same concentration of ZnPP was perfused with CO supplemented at 4 µM, the concentration that can sufficiently compensate the CO suppression by ZnPP. Effects of these reagents on the vascular resistance were also examined in livers pretreated with endothelin-1 (ET-1); in these experiments, the reagents were added to the perfusate for 5 min followed by the infusion of 1 nM ET-1 for 1 min. The dose of ET-1 was estimated to be ~30 pmol/min for 1 min. This dose of ET-1 was reported to evoke site-specific constriction of microvessels including portal venules and sinusoids but not of larger portal veins (11, 34). We confirmed that no significant reduction of bile flow was observed after injecting this dose of ET-1 (data not shown). This observation convinced us that there was little involvement if any of vasoconstriction at the level of the portal veins. In some experiments, desired concentrations of Nomega -nitro-L-arginine methyl ester (L-NAME) were added to the perfusate to suppress endogenously generated NO. ET-1 and L-NAME were purchased from Sigma. In all experiments, bile samples were collected every 5 min to monitor the bile output.

Digital microfluorography of sinusoids in perfused liver. To examine alterations in the diameter of sinusoids, digital microangiography was carried out in perfused rat livers by using real-time laser confocal microscopy as described elsewhere (10, 29). Briefly, the surface of the perfused liver was observed through an inverted-type intravital microscope assisted by a line-scan laser confocal imager (Insight/TMD300, Meridian Far East, Tokyo, Japan), and the hepatic microcirculation was visualized by a 10-bit color chilled, intensified charge-coupled device camera (C5810-01, Hamamatsu Photonics, Hamamatsu). This system allowed us to acquire the confocal fluorescence images at a video-rate speed (30 frames/s); images were optically sliced to the desired width, which ranged from 1 to 20 µm. To visualize the hepatic sinusoidal vessels, 100 µl of 1% of FITC-dextran solution were injected transportally every 2 or 5 min after the start of experiments, and the microvasculature was visualized by epi-illumination at 488 nm using an argon laser light source. The width of the confocal plane along the z-axis was set up to 2 µm to collect the fluorescent images.

Determinations. Rat liver homogenates were subjected to SDS-PAGE, transferred to a Millipore Immobilon polyvinylidene difluoride transfer membrane, and then served as samples for Western blot analysis, as described previously (10). HO-1 and HO-2 proteins were visualized using specific antibodies against rat HO-1 and HO-2, namely, GTS-1 and GTS-2, respectively (10).

Concentrations of CO in the effluent of perfused liver was determined by detecting ferrous CO complex of myoglobin spectrophotometrically (32). Bilirubin IXalpha concentrations in bile samples were determined by ELISA using the monoclonal antibody 24G7, which recognizes both conjugated and unconjugated bilirubin IXalpha fractions as described previously (39, 41). All experimental procedures for bilirubin measurements were carried out under subdued light.

Hepatic microsomal cytochrome P-450 contents were measured by the spectrophotometric method of Omura and Sato (19). Activities of HO in liver tissues were determined by measuring the bilirubin formation as described elsewhere (42). Protein was determined according to the method of Lowry et al. (13).

Immunohistochemistry of liver HO-1 and HO-2. Frozen sections (7 µm thick) were prepared from rat livers. After fixation with acetone, the sections were treated with avidin, biotin, and normal horse serum to minimize the nonspecific staining. These tissues were incubated with monoclonal antibodies to GTS-1 or GTS-2, dissolved in 1% BSA-PBS at a final concentration of 1 µg/ml, for at least 2 h at 25°C. After several washes with PBS, the sections were stained with anti-mouse IgG for 1 h (Vectastain Elite ABC kit, Vector, CA). To prevent endogenous peroxidase reactions, the samples were pretreated with 0.3% H2O2 in cold methanol for 30 min and subsequently incubated with avidin and horseradish peroxidase-conjugated biotin for 30 min. Finally, 0.1 mg/ml of 3,3'-diaminobenzidine tetrahydrochloride were applied to sections for 5 min. The sections were counterstained with methyl green after fixation with 20% formaldehyde for 20 min, and slides were coverslipped with aqueous mounting medium. The immunohistochemical staining patterns were examined using the samples collected from at least three individual rats. To confirm the specificity of immunohistochemical localization, antibodies preabsorbed with an excess of adequate antigens in advance were used.

Statistical analyses. All data in the present study are expressed as means ± SE of measurements. Differences in the mean values among the groups were analyzed by one-way ANOVA combined with Scheffé's-type multiple comparison test. P values <0.05 were considered statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

HO-1 expression and CO generation in the hemin-treated liver. Figure 1 illustrates time history of the HO-1 expression in the liver of rats treated with an intraperitoneal injection of 40 µmol/kg hemin. As shown in Fig. 1A, the HO activity in the tissue increased time dependently and reached a maximum at 12 h, plateaued until 18 h, and then was followed by a reduction at 24 h. Results for the immunoreactive HO-1 protein also displayed a time course similar to the results for HO activity, as assessed by Western blot analysis (Fig. 1B). Because the expression of HO-2, as assessed by Western blot analysis (data not shown), showed no significant changes during the 18-h period, these results indicate that an increase in the HO activity is attributable to the increase in HO-1 protein expression. On the other hand, the time course of the CO flux in the venous effluents exhibited quite different pictures, as indicated in Fig. 1C. At 6 h, the flux displayed no significant elevation, in contrast to the HO-1 activity, which was 2.7-fold greater than that in the control, as shown in Fig. 1A. However, at 12 h, when the enzyme activity reached a maximum level, the CO flux did not show any significant changes. However, at 18 h, the CO flux exhibited a marked elevation, being as much as 4.5-fold greater than the control flux. The elevation was markedly repressed at 24 h, at which time HO-1 protein expression exhibited a fall nearly to control levels (Fig. 1B).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Time history of the heme oxygenase (HO) activity, the protein expression of HO-1, and carbon monoxide (CO) generation in livers from the hemin-treated rats. A-C: temporal alterations in the microsomal enzyme activity, Western blotting analysis, and flux of CO measured in the venous samples collected from the perfused liver, respectively. D: time course of contents of cytochrome P-450 per mg microsomal protein. Note that a marked increase in the CO flux occurred at 18 h, whereas the enzyme expression and activity reached a maximum level at 12 h. Data in A, C, and D represent means ± SE of measurements from 4-5 separate livers. * P < 0.05 compared with control values measured at time 0. dagger  P < 0.05 compared with values at 12 h. # P < 0.05 compared with values at 18 h.

Differences in time history between the HO-1 induction and CO generation led us to examine alterations in amounts of the substrate available for the HO reaction. We therefore examined contents of cytochrome P-450, a major heme protein that could provide protoheme IX as a substrate for HO. As seen in Fig. 1D, contents of cytochrome P-450 increased gradually during the initial 12 h. At 18 h, however, the liver displayed as much as a 45% decrease in microsomal cytochrome P-450 contents compared with that treated for 12 h.

Reduction of the basal vascular resistance in the CO-overproducing liver. We then investigated whether the liver undergoing the HO-1 induction alters its organ functions, such as vascular resistance and bile formation. As seen in Table 1, these functional parameters exhibited no significant changes in the 12-h hemin-treated liver. However, the liver exposed to the 18-h hemin treatment displayed a 13% reduction of the basal vascular resistance. Bile output was elevated concurrently with reduction of the resistance, showing a 10% increase vs. control values. Although small, these changes were statistically significant. We also examined differences in the biliary flux of bilirubin IXalpha as an index of the HO-mediated heme degradation, which became 4.8-fold greater at 18 h than that shown in the controls, the value being stoichiometric to the increase in the venous CO flux. These results indicate that alterations in the vascular resistance and bile output are the events occurring in concert with the overproduction of CO.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Changes in the baseline vascular resistance, bile output, and biliary flux of bilirubin IXalpha in the hemin-challenged rat liver

Intralobular distribution of HO-1 expression in the hemin-pretreated liver. Figure 2 illustrates immunohistochemical analysis using a monoclonal antibody against HO-1. In the control liver, HO-1 was densely stained in cells located in nonparenchymal regions, whereas only little staining was observed in parenchymal cells (Fig. 2A). The sites of the HO-1 expression corresponded to the distribution of Kupffer cells as described previously (10). In contrast, HO-2 was mainly observed in the parenchymal cells (data not shown) (10). After the 18-h hemin treatment, HO-1 expression was demonstrated not only in Kupffer cells but was also prominent in hepatocytes throughout the entire lobule (Fig. 2B). On the other hand, HO-2 expression in the hemin-treated liver displayed no detectable changes between the control and the 18-h hemin-treated livers (data not shown). Together with the data from Fig. 1, A-C, these results suggest that the overproduction of CO in the livers of hemin-treated rats is ascribable to a marked induction of HO-1 in parenchymal cells and to the increase in availability of cytochrome P-450-derived heme.


View larger version (143K):
[in this window]
[in a new window]
 
Fig. 2.   Immunohistochemical determination of HO-1 expression in the hemin-pretreated rat livers. The 7-µm-thick frozen sections of rat livers were immunostained with GTS-1. A and B: samples collected from the control and 18-h hemin-treated livers, respectively. Bar = 100 µm. P and C denote portal and central venules, respectively.

Effects of HbO2 and ZnPP on vascular resistance. We investigated whether reduction of vascular resistance observed at 18 h of treatment is indeed controlled by mechanisms involving CO. Figure 3 illustrates alterations in the baseline vascular resistance and the sinusoidal caliber in response to administration of 0.5 g/dl HbO2, a CO-trapping reagent. Figure 3A shows that, immediately after the start of administration, the vascular resistance exhibited a marked elevation, being 33% greater than the baseline level. When HbO2 was eliminated from the perfusion circuit at 10 min after the administration, the increased resistance decreased back to the baseline level within 20 min, showing that the HbO2-induced elevation of resistance is a reversible event. On the other hand, metHb, a reagent that could scavenge NO but not CO, did not alter the vascular resistance. Furthermore, administration of NO synthase inhibitors such as L-NAME and aminoguanidine did not increase the resistance (data not shown). These results suggest that CO rather than NO plays a major role in lowering the baseline vascular resistance under the current experimental conditions. To specify the role of CO generated in intra- and extravascular compartments, effects of liposomal encapsulation of HbO2 on the resistance were also examined. Administration of HbV-O2 induced no significant changes in vascular resistance, indicating that CO generated in the extravascular space is important in lowering the baseline vascular resistance.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of oxyhemoglobin (HbO2), methemoglobin (metHb), and liposome-encapsulated hemoglobin (HbV) on the vascular resistance in perfused rat liver exposed to the 18-h hemin treatment. In A, open triangles denote data collected from the HO-1-induced liver receiving no hemoglobin derivatives. open circle  and , Data from livers receiving HbO2 and HbV, respectively. , Data from metHb-treated liver. Results are means ± SE of 6 separate experiments, expressed as percentages vs. basal vascular resistance in the 18-h hemin-treated liver (see Table 1). * P < 0.01 compared with control (triangle ). B: time course of alterations in the sinusoidal caliber during HbO2 administration. Twenty individual sinusoids in a representative liver preparation were chosen for measurements, and their changes in caliber were determined before and 2, 5, 10, 15, and 20 min after the start of the HbO2 administration. HbO2 was eliminated from the perfusion circuit at 10 min. Bold lines indicate means ± SE of the 20 measurements in the representative experiment.

Figure 3B illustrates alterations in the sinusoidal caliber determined by FITC-dextran-assisted microangiography during HbO2 administration. The vascular components responsible for the HbO2-induced elevation of resistance appear to involve sinusoidal vessels. In good agreement with our previous observation in the control perfused liver (31), a large variation of the caliber not only among different sinusoids but among different sites in the same sinusoidal segment was observed in the 18-h hemin-treated livers (data not shown). In response to the addition of HbO2 to the perfusate, sinusoids of these livers displayed a significant decrease in the caliber as early as 2 min after the start of administration, showing about a 20% decrease. The HbO2-induced changes in sinusoids were reversed with elimination of HbO2, suggesting this event is reversible.

A similar elevation of the vascular resistance was also observed after administration of an HO inhibitor (Figure 4). ZnPP (1 µM) abolished the hemin-induced reduction and caused further elevation of the vascular resistance (about a 20% increase compared with that in the control liver). The ZnPP-induced elevation was significantly lowered by coperfusion with 4 µM CO, although not completely abolished. These results suggest that, in the hemin-treated liver, the low vascular resistance observed is caused at least in part by CO endogenously generated by HO.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of zinc protoporphyrin IX (ZnPP), an inhibitor of HO, on baseline vascular resistance in the 18-h hemin-pretreated rat liver (H18). Baseline vascular resistance was plotted as relative values vs. those in control. Namely, the value 100 indicates 2.42 ± 0.13 cmH2O · g liver · min · ml-1. ZnPP was administered at final concentrations of 1 mM. When added, 4 µM CO was applied to the perfusate 5 min before ZnPP administration. Data are means ± SE of measurements from 6-9 separate livers. * P < 0.05 compared with control value. dagger  P < 0.05 compared with values measured in 18-h hemin-treated liver. # P < 0.05 compared with values in 18-h hemin-treated liver perfused in the presence of 1 µM ZnPP.

Overproduction of CO diminished ET-1-elicited sinusoidal constriction. The above studies with different Hb derivatives showed that the reduction of basal vascular resistance in the HO-1-induced liver is attributable to relaxation of microvessels by overproduced CO. This finding tempted us to examine whether the CO overproduction can predispose sinusoids to actively relax even under stimulated conditions. To this end, we applied ET-1 to constrict microvessels. This vasoconstrictive peptide can increase sinusoidal tone at a dose that does not evoke constriction of larger portal veins (34) but elicits that of microvessels involving portal venules (11) and/or sinusoids (3). As shown in Fig. 5, 1.0 nM but not 0.5 nM ET-1 evoked an increase in the vascular resistance. In contrast, the liver undergoing the 18-h hemin treatment displayed a 45% decrease in the ET-1-elicited elevation of the resistance, whereas that exposed to the 12-h treatment exhibited no changes. We did not observe interlobular heterogeneity of the perfusion in these livers as assessed by the transportal injection of trypan blue at the end of experiments (data not shown). In addition, during the ET-1 administration, the bile output did not show any detectable decrease. On the other hand, administration of 5 nM ET-1 evolved a twice greater increase in the resistance, which coincided with a marked reduction of the bile output and an interlobular heterogeneity in the perfusion. Considering that greater doses of ET-1 are known to evoke cholestatic changes in parallel with a marked constriction of portal veins (3, 34), these results suggest that the increase in vascular resistance elicited by ET-1 at <1 nM is ascribable to vasoconstriction of microvasculature, including portal venules and/or sinusoids, rather than to vasoconstriction of larger portal veins. On the basis of these data, we compared the differences between the control and the 18-h hemin-treated livers in the ET-1-induced vascular response at 1 nM.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Differences in responses of endothelin-1 (ET-1)-induced elevation of the vascular resistance in HO-1-induced livers. ET-1 was administered transportally at concentrations ranging from 0.1 to 1 nM for 1 min. Values of change in (Delta ) vascular resistance were determined by calculating the difference between the resistance measured at 4 min after ET-1 injection and that measured before injection.  and triangle , Data collected from control and 12-h hemin-treated livers, respectively. , Data from 18-h hemin-treated livers. Note that the liver undergoing 18-h hemin treatment specifically decreased its vasoconstrictive sensitivity to ET-1. * P < 0.05 compared with control value. dagger  P < 0.05 compared with values measured in 18-h hemin-treated liver. # P < 0.05 compared with values in 18-h hemin-treated liver perfused in the presence of 1 µM ZnPP. Inset: effects of Nomega -nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, on ET-1-induced elevation of resistance. open circle  and , data collected from 12-h hemin-treated livers in the absence or presence of 1 mM L-NAME, respectively. Closed and open arrows indicate time points when L-NAME and ET-1 were administered to the perfusate, respectively. Mean value of the Delta vascular resistance induced by 1 nM ET-1 in 18-h hemin-treated liver (see  in main panel) was expressed as 100%. Data are means ± SE of 5 separate experiments.

Because ET-1 is known to stimulate NO generation from endothelial cells and to help reduce the ET-1-elicited increase in the vascular tone (26), we inquired whether the hemin-treated liver could display greater sensitivity of the NO-mediated relaxation in response to the ET-1 administration and thereby exhibit smaller vasoconstrictive responses than the ordinary liver. Figure 5, inset, illustrates the effects of administration of 1 mM L-NAME on the ET-1-induced elevation of the vascular resistance in the hemin-treated liver. The increase in the vascular resistance by ET-1 was not significantly altered by the presence of the NO synthase inhibitor. These results suggest that, at least under the current experimental conditions, the decreasing sensitivity of the resistance in response to the ET-1 stimulation observed at 18 h is unlikely to be NO dependent.

Table 2 displays effects of ZnPP, an HO inhibitor, on resistance in the HO-1-induced liver under the ET-1-stimulated conditions. The ET-1-induced elevation of the resistance was significantly reduced in the 18-h treated livers compared with that in the control. In the presence of 1 µM ZnPP in the perfusate, the ET-1-induced response was not reduced and further increased to 120% of the control value. The ZnPP-induced changes were attenuated in part by supplement of 4 µM CO. These results suggest that the ET-1-induced elevation of the resistance was reduced in part by CO overproduced by HO in the 18-h hemin-treated liver.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effects of ZnPP and CO on the ET-1-induced changes in the vascular resistance in the 18-h hemin-treated liver


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Previous studies suggested that, under various disease conditions, HO-1 is induced and thereby causes alterations in cell and organ functions (1, 2, 5, 20). However, outcome of the functional alterations on the enzyme induction was not sufficiently elucidated in these previous studies. The present study provides substantial evidence that CO overproduced by the inducible HO serves as an endogenous vasodilating factor that alters the hepatic vascular resistance. Quantitative determination of CO as a terminal product of the HO pathway disclosed that, under our experimental conditions, actual generation of the product rather than amounts of the enzyme expressed in the tissue dictated changes in the vascular function. Immunohistochemical analysis illustrates that both parenchymal and nonparenchymal cells constitute major cellular components responsible for the regional CO production. Furthermore, entrapment of CO generated in situ by HbO2 as well as enzyme inhibition by ZnPP elicited marked elevations of resistance, suggesting that CO is a determinant for the decreased vascular resistance in the HO-1-induced liver, at least under the current experimental conditions using isolated perfused preparations.

We reported that CO generated by the constitutive isozyme of HO, i.e., HO-2, plays a major role in maintaining sinusoids in a relaxing state under ordinary conditions (10, 32). The biological significance of the HO-1-mediated vasorelaxing mechanism depicted in this study appears to be distinct from that of the HO-2-mediated one, although these two isozymes share the same reaction product as the vasorelaxing reagent. Because of the greater Michaelis-Menten constant value for protoheme IX (16), an induction of HO-1 under disease conditions that induce overloading of heme iron observed in sepsis and hemolysis has been thought to play an important role in normalizing the amounts of intracellular free heme molecules. At the same time, the enzyme induction could help ameliorate tissue susceptability to oxidative stress through a reduction of excessive heme loading as well as generation of anti-oxidant bile pigments such as bilirubin (31, 39). With overloading of free protoheme IX, the liver can utilize several possible mechanisms to reduce the amount of free heme molecules overloaded in hepatocytes and to degrade them. First, once uptaken into the parenchyma, protoheme IX could be degraded by HO-2 constitutively expressed in the cells. Second, free protoheme IX can be captured by empty heme-binding pockets of apo-heme proteins (e.g., cytochrome P-450 and tryptophan 2,3-dioxygenase) in the cells (7, 38). A portion of excessive heme molecules that escaped from the aforementioned mechanisms could be excreted directly into the bile (30). Finally, protoheme IX evokes transcriptional upregulation of HO-1 in the cells and helps its oxidative degradation through the newly induced enzyme (15). When the greater catalytic ability of HO-1 over HO-2 (15) is considered, this mechanism could serve as an important fail-safe mechanism that is necessary not only to ameliorate the toxicity of protoheme IX as a prooxidant reagent but also to help guarantee an ample perfusion in the hepatic vascular system through the mechanism involving CO under the aforementioned disease conditions. Considering our previous data (10, 32), these results suggest that HO-1 and HO-2 have distinct roles in regulation of hepatic microvascular tone under pathological and physiological conditions, respectively.

It should be noted that CO overproduction occurred with a certain lag time after the enzyme induction reached a maximum level. Although whole pictures of the mechanisms are presently unknown, there are several possible mechanisms to be considered. First, the HO reaction requires NADPH-cytochrome P-450 reductase for an electron donor system. At 12 h, when the amounts of cytochrome P-450 become maximum, HO could share this electron-donating system with cytochrome P-450 monooxygenases and would not exert its maximum catalytic activity. Second, differences in availability of free heme molecules as a substrate of HO between naive heme proteins and those undergoing oxidative insults should be considered. Previous data showed that cytochrome P-420, a denatured heme protein derived from oxidative modification of cytochrome P-450, serves as a better substrate for the HO reaction than the naive protein (12). It has also been suggested that, once exposed acutely to xenobiotics such as acetaminophen, hepatic cytochrome P-450 can undergo oxidative destruction through its active intermediates and can induce CO overproduction mediated by HO-2, even when the inducible enzyme is not overexpressed (17). These previous observations led us to speculate that availability of NADPH-mediated electron donation and oxidative susceptability of cytochrome P-450 proteins could be factors that determine temporal discrepancy between the HO-1 expression and CO generation. Although further investigation is obviously necessary to solve these questions, the current results shed light on the importance of measurements of products such as CO and/or bilirubin IXalpha to study the effects of HO-1 induction on organ functions.

It has been shown in the liver that at least two distinct compartments in the vascular system are responsible for controlling the resistance: portal veins and microvessels such as portal venules, sinusoids, and central venules. The current study provided several lines of data showing that, in the HO-1-induced liver, microvessels constitute a major vascular compartment sensing the regional CO generation. First, when administration of HbO2 or ZnPP abolished reduction of the basal resistance and further increased the resistance, presumably by canceling the HO-2-derived CO, there was neither a reduction of the basal bile output nor an interlobular heterogeneity of the perfusion, whereas a decrease in the perfusion caused by vasoconstriction at the portal levels is known to result in these changes (34). Second, elimination of CO by HbO2, which can diffuse into the space of Disse, but not by HbV, which is restricted to access the space, preferentially constricted sinusoids in the HO-1-induced liver. Finally, when undergoing perturbation by nanomolar levels of ET-1, a substantial difference in the vascular resistance became evident between the control and the HO-1-induced liver. This event can only be explained by differences in HO-1 expression and CO generation but not by differences of HO-2 expression between the groups, inasmuch as no fundamental differences in the HO-2 expression in the parenchyma were observed immunohistochemically. We were unable to observe a reduction of the ET-1-elicited constriction of the preterminal portal venules, a putative resistant vessel responding to low doses of this peptide constrictor (11), in the hemin-treated liver because intravital microscopy of the hepatic microcirculation under epi-illumination in rats did not allow us to observe these vessels in portal regions directly (32). However, it appears possible that vascular tone of such portal venules can be regulated by overproduced CO, since these vessels stand in a periportal domain adjacent to hepatocytes that abundantly express HO-1 in the hemin-treated liver, as shown by immunohistochemistry in Fig. 2. Further evaluation is obviously necessary to specify which portion(s) of microvessels is mainly responsible for the CO-mediated attenuation of the ET-1-induced constriction. In summary, the current results shed light on a possible role of CO overproduction in the mechanisms for hyporeactivity of the hepatoportal vascular system observed in a variety of experimental disease models accompanied by HO-1 induction, such as carbon tetrachloride-induced cirrhosis (8), portal hypertension (9), and hemorrhagic shock (2). Further investigation is necessary to confirm whether the CO-mediated vasorelaxing mechanisms are applicable to blood-perfused innervated livers in vivo under these disease models.


    ACKNOWLEDGEMENTS

We thank Drs. Takuya Tamatani and Kensuke Suzuki (Pharmaceutical Frontier Research Laboratories, JT, Inc.) for technical support.


    FOOTNOTES

This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, by grants from Keio University School of Medicine and from Keio Medical Research Fund, by Surveys and Research on Specific Diseases from the Ministry of Health in 1998, and in part by Takeda Science Foundation.

R. Takamiya was an undergraduate student of Science University of Tokyo. N. Goda is a research fellow supported by the Japan Society for the Promotion of Science in 1998.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: Y. Ishimura, Dept. of Biochemistry, School of Medicine, Keio Univ., 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan (E-mail: yishimur{at}mc.med.keio.ac.jp).

Received 21 May 1999; accepted in final form 10 August 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bauer, I., G. A. Wanner, H. Rensing, C. Alte, E. A. Miescher, B. Wolf, B. H. J. Pannen, M. G. Clemens, and M. Bauer. Expression pattern of heme oxygenase isozymes 1 and 2 in normal and stress-exposed rat liver. Hepatology 27: 829-838, 1998[Medline].

2.   Bauer, M., B. H. J. Pannen, I. Bauer, C. Herzog, G. A. Wanner, R. Hanselmann, J. X. Zhang, M. G. Clemens, and R. Larsen. Evidence for a functional link between stress response and vascular control in hepatic portal circulation. Am. J. Physiol. 271 (Gastrointest. Liver Physiol. 34): G929-G935, 1996[Abstract/Free Full Text].

3.   Bauer, M., J. X. Zhang, and M. G. Clemens. ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G143-G149, 1994[Abstract/Free Full Text].

4.   Brüne, B., and V. Ullrich. Inhibition of platelet aggregation by carbon monoxide mediated by activation of guanylate cyclase. Mol. Pharmacol. 32: 497-504, 1987[Abstract].

5.   Cantoni, L., C. Rossi, M. Rizzardini, M. Gadina, and P. Ghezzi. Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Biochem. J. 279: 891-894, 1991[Medline].

6.   Choi, A. M. K., and J. Alam. Heme oxygenase-1: Function, regulation and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15: 9-19, 1996[Abstract].

7.   Correia, M. A., G. C. Farrell, R. Schmid, P. R. Ortiz de Montellano, G. S. Yost, and B. A. Mico. Incorporation of exogenous heme into hepatic cytochrome P-450 in vivo. J. Biol. Chem. 254: 15-17, 1979[Abstract].

8.   Farrell, G. C., and L. Zaluzny. Hepatic heme metabolism and cytochrome P450 in cirrhotic rat liver. Gastroenterology 89: 172-179, 1985[Medline].

9.   Fernandez, M., and H. L. Bonkovsky. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 29: 1672-1679, 1999[Medline].

10.   Goda, N., K. Suzuki, M. Naito, S. Takeoka, E. Tsuchida, Y. Ishimura, T. Tamatani, and M. Suematsu. Distribution of heme oxygenase isoforms in rat liver: topographic basis for carbon monoxide-mediated microvascular relaxation. J. Clin. Invest. 101: 604-612, 1998[Abstract/Free Full Text].

11.   Kaneda, K., W. Ekataksin, M. Sogawa, A. Matsumura, A. Cho, and N. Kawada. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: local constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 27: 735-747, 1998[Medline].

12.   Kutty, R. K., R. F. Daniel, D. E. Ryan, W. Levin, and M. D. Maines. Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase. Arch. Biochem. Biophys. 260: 638-644, 1988[Medline].

13.   Lowry, O. H., N. J. Rosebrough, A. R. Farr, and R. J. Randell. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951[Free Full Text].

14.   Maines, M. D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2: 2557-2568, 1988[Abstract/Free Full Text].

15.   Maines, M. D., G. M. Trakshel, and R. K. Kutty. Characterization of two constitutive forms of rat liver microsomal heme oxygenase: only one molecular species of the enzyme is inducible. J. Biol. Chem. 261: 411-419, 1986[Abstract/Free Full Text].

16.   McCoubrey, W. K., Jr., T. J. Huang, and M. D. Maines. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247: 725-732, 1997[Abstract].

17.   Mori, M., M. Suematsu, T. Kyokane, T. Sano, H. Suzuki, T. Yamaguchi, Y. Ishimura, and H. Ishii. Carbon monoxide-mediated alterations in paracellular permeability and vesicular transport in acetaminophen-treated perfused rat liver. Hepatology 30: 160-168, 1999[Medline].

18.   Naito, M., and E. Wisse. Filtration effect of endothelial fenestrations on chylomicron transport in neonatal rat liver sinusoids. Cell Tissue Res. 190: 371-382, 1978[Medline].

19.   Omura, T., and R. Sato. The carbon monoxide-binding pigment of liver microsome. J. Biol. Chem. 239: 2370-2378, 1964[Free Full Text].

20.   Poss, K. D., and S. Tonegawa. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 94: 10925-10930, 1997[Abstract/Free Full Text].

21.   Rich, A., G. Farrugia, and J. L. Rae. Carbon monoxide stimulates a potassium-selective current in rabbit corneal epithelial cells. Am. J. Physiol. 267 (Cell Physiol. 36): C435-C442, 1994[Abstract/Free Full Text].

22.   Rudolph, A. S., H. Spielberg, B. J. Spargo, and N. Kossovsky. Histopathologic study following administration of liposome-encapsulated hemoglobin in the normovolemic rats. J. Biomed. Mater. Res. 29: 189-196, 1995[Medline].

23.   Sakai, H., K. Hamada, S. Takeoka, H. Nishide, and E. Tsuchida. Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol. Prog. 12: 119-125, 1996[Medline].

24.   Sakai, H., S. Takeoka, H. Yokohama, Y. Seino, H. Nishide, and Y. Tsuchida. Purification of concentrated hemoglobin using organic solvent and heat treatment. Prot. Exp. Pur. 4: 563-569, 1993[Medline].

25.   Sano, T., M. Shiomi, Y. Wakabayashi, Y. Shinoda, N. Goda, T. Yamaguchi, Y. Nimura, Y. Ishimura, and M. Suematsu. Endogenous carbon monoxide suppression stimulates bile acid-dependent biliary transport in perfused rat liver. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G1268-G1275, 1997[Abstract/Free Full Text].

26.   Schini, V. B., N. D. Kim, and P. M. Vanhoutte. The basal and stimulated release of EDRF inhibits the contractions evoked by endothelin-1 and endothelin-3 in aortae of normotensive and spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 17: S267-S271, 1991[Medline].

27.   Schoendorf, T. H., M. Rosenberg, and F. K. Beller. Endotoxin-induced disseminated intravascular coagulation in nonpregnant rats. A new experimental model. Am. J. Pathol. 65: 51-58, 1971[Medline].

28.   Shibahara, S., R. Muller, H. Taguchi, and T. Yoshida. Cloning and expression of cDNA of rat heme oxygenase. Proc. Natl. Acad. Sci. USA 82: 7865-7869, 1985[Abstract].

29.   Shiomi, M., Y. Wakabayashi, T. Sano, Y. Shinoda, Y. Nimura, Y. Ishimura, and M. Suematsu. Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver. Hepatology 27: 108-115, 1998[Medline].

30.   Snyder, A. L., and R. Schmid. The conversion of hematin to bile pigment in the rat. J. Lab. Clin. Med. 65: 817-824, 1965.

31.   Stocker, R., A. N. Glazer, and B. N. Ames. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA 84: 5918-5922, 1987[Abstract].

32.   Suematsu, M., N. Goda, T. Sano, S. Kashiwagi, Y. Shinoda, and Y. Ishimura. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J. Clin. Invest. 96: 2431-2437, 1995[Medline].

33.   Suematsu, M., S. Kashiwagi, T. Sano, N. Goda, Y. Shinoda, and Y. Ishimura. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem. Biophys. Res. Commun. 205: 1333-1337, 1994[Medline].

34.   Tanaka, A., K. Katagiri, M. Hoshino, T. Hayakawa, K. Tsukada, and T. Takeuchi. Endothelin-1 stimulates bile acid secretion and vesicular transport in the isolated perfused liver. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G324-G329, 1994[Abstract/Free Full Text].

35.   Tenhunen, R., H. S. Marver, and R. Schmid. The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J. Lab. Clin. Med. 75: 410-421, 1970[Medline].

36.   Verma, A., D. J. Hirsch, C. E. Glatt, G. V. Ronnett, and S. H. Snyder. Carbon monoxide: a putative neural messenger. Science 259: 381-384, 1993[Medline].

37.   Wisse, E., R. B. DeZanger, K. Charels, P. van der Smissen, and R. S. McCuskey. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5: 683-692, 1985[Medline].

38.   Wyman, J. F., J. L. Gollan, W. Settle, G. C. Farrell, and M. A. Correia. Incorporation of hemoglobin haem into the rat hepatic heamoproteins tryptophan pyrrolase and cytochrome P-450. Biochem. J. 238: 837-846, 1986[Medline].

39.   Yamaguchi, T., F. Horio, T. Hashizume, M. Tanaka, S. Ikeda, A. Kakinuma, and H. Nakajima. Bilirubin is oxidized in rats treated with endotoxin and acts as a physiological antioxidant synergistically with ascorbic acid in vivo. Biochem. Biophys. Res. Commun. 214: 11-19, 1995[Medline].

40.   Yamaguchi, T., Y. Wakabayashi, M. Tanaka, T. Sano, H. Ishikawa, H. Nakajima, M Suematsu, and Y. Ishimura. Taurocholate induces directional transport of bilirubin into bile in the perfused rat liver. Am. J. Physiol. 270 (Gastrointest. Liver Physiol. 33): G1028-G1032, 1996[Abstract/Free Full Text].

41.   Yasuhara, I., M. Yamazaki, S. Shimizu, K. Shimizu, T. Yamaguchi, and H. Nakajima. Anti-bilirubin monoclonal antibody II. Enzyme-linked immunosorbent assay for bilirubin fractions by combination of two monoclonal antibodies. Biochim. Biophys. Acta 967: 261-266, 1988[Medline].

42.   Yoshida, T., and G. Kikuchi. Reaction of the microsomal heme oxygenase with cobaltic protoporphyrin IX, an extremely poor substrate. J. Biol. Chem. 253: 8479-8482, 1978[Abstract].


Am J Physiol Gastroint Liver Physiol 277(5):G1088-G1096
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society